Evidence map›Paper›PMID 27507947›Full record

ArticleFrontiers in pharmacology2016

Scorpion Venom Heat-Resistant Peptide Protects Transgenic Caenorhabditis elegans from β-Amyloid Toxicity.

Xiao-Gang Zhang, Xi Wang, Ting-Ting Zhou, Xue-Fei Wu, Yan Peng, Wan-Qin Zhang, Shao Li, Jie Zhao

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Journal of bacteriology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Frontiers in aging neuroscience · 2024
    Article
  11. The journal of venomous animals and toxins including tropical diseases · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Exendin-4 alleviates β-Amyloid peptide toxicityFrontiers in aging neuroscience · 2022
    Article
  17. Ginsenoside Rd protects transgenicFrontiers in pharmacology · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiao-Gang ZhangDepartment of Physiology, Dalian Medical University Dalian, China.
Xi WangDepartment of Physiology, Dalian Medical University Dalian, China.
Ting-Ting ZhouDepartment of Neurology, the First Affiliated Hospital of Dalian Medical University Dalian, China.
Xue-Fei WuDepartment of Physiology, Dalian Medical University Dalian, China.
Yan PengDepartment of Physiology, Dalian Medical University Dalian, China.
Wan-Qin ZhangDepartment of Physiology, Dalian Medical University Dalian, China.
Shao LiDepartment of Physiology, Dalian Medical University Dalian, China.
Jie ZhaoDepartment of Physiology, Dalian Medical UniversityDalian, China; Liaoning Engineering Technology Centre of Target-based Nature Products for Prevention and Treatment of Ageing-related NeurodegenerationDalian, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scorpion venom heat-resistant peptide (SVHRP) is a component purified from Buthus martensii Karsch scorpion venom. Our previous studies found SVHRP could enhance neurogenesis and inhibit microglia-mediated neuroinflammation in vivo. Here, we use the transgenic CL4176, CL2006, and CL2355 strains of Caenorhabditis elegans which express the human Aβ1-42 to investigate the effects and the possible mechanisms of SVHRP mediated protection against Aβ toxicity in vivo. The results showed that SVHRP-fed worms displayed remarkably decreased paralysis, less abundant toxic Aβ oligomers, reduced Aβ plaque deposition with respect to untreated animals. SVHRP also suppressed neuronal Aβ expression-induced defects in chemotaxis behavior and attenuated levels of ROS in the transgenic C. elegans. Taken together, these results suggest SVHRP could protect against Aβ-induced toxicity in C. elegans. Further studies need to be conducted in murine models and humans to analyze the effectiveness of the peptide.

Indexed as

alzheimer’s diseaseamyloid beta-peptidebehaviorC. elegansscorpion venom heat-resistant peptide

Identifiers

PMID27507947
PMCPMC4960250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.